Icon plc [ICLR] vs Charles River [CRL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Icon plc wins in 16 metrics, Charles River Laboratories International, Inc. wins in 4 metrics, with 0 ties. Icon plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Icon plc | Charles River Laboratories International, Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.52 | 681.33 | Icon plc |
| Price-to-Book Ratio | 0.94 | 2.61 | Icon plc |
| Debt-to-Equity Ratio | 38.26 | 81.95 | Icon plc |
| PEG Ratio | -0.16 | 20.54 | Charles River Laboratories International, Inc. |
| EV/EBITDA | 7.82 | 12.23 | Icon plc |
| Profit Margin (TTM) | 7.40% | -3.60% | Icon plc |
| Operating Margin (TTM) | 12.67% | 4.51% | Icon plc |
| EBITDA Margin (TTM) | 12.67% | 4.51% | Icon plc |
| Return on Equity | 6.27% | -4.23% | Icon plc |
| Return on Assets (TTM) | 4.20% | 4.24% | Charles River Laboratories International, Inc. |
| Free Cash Flow (TTM) | $1.12B | $518.49M | Icon plc |
| 1-Year Return | 0.36% | 25.47% | Charles River Laboratories International, Inc. |
| Price-to-Sales Ratio (TTM) | 1.11 | 2.06 | Icon plc |
| Enterprise Value | $11.90B | $10.72B | Icon plc |
| EV/Revenue Ratio | 1.47 | 2.67 | Icon plc |
| Gross Profit Margin (TTM) | 27.14% | 31.15% | Charles River Laboratories International, Inc. |
| Revenue per Share (TTM) | $102 | $81 | Icon plc |
| Earnings per Share (Diluted) | $7.42 | $-2.90 | Icon plc |
| Beta (Stock Volatility) | 1.28 | 1.62 | Icon plc |
| Short % of Float | 3.82% | 10.71% | Icon plc |
Icon plc vs Charles River Laboratories International, Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Icon plc | 1.05% | -2.97% | 26.93% | 51.34% | -19.88% | -21.70% |
| Charles River Laboratories International, Inc. | 0.51% | 1.09% | 24.94% | 24.02% | -4.89% | -6.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Icon plc | 0.36% | -37.56% | -31.10% | 128.30% | 504.05% | 1,004.91% |
| Charles River Laboratories International, Inc. | 25.47% | -10.71% | -46.99% | 128.42% | 379.20% | 406.37% |
Performance & Financial Health Analysis: Icon plc vs Charles River Laboratories International, Inc.
| Metric | ICLR | CRL |
|---|---|---|
| Market Information | ||
| Market Cap | $8.98B | $8.28B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 968,191 | 761,885 |
| 90 Day Avg. Volume | 934,860 | 865,618 |
| Last Close | $147.72 | $188.47 |
| 52 Week Range | $66.57 - $211.00 | $143.06 - $228.88 |
| % from 52W High | -29.99% | -17.66% |
| All-Time High | $347.72 (Jul 15, 2024) | $460.21 (Sep 20, 2021) |
| % from All-Time High | -57.52% | -59.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | -0.01% |
| Quarterly Earnings Growth | -0.99% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | -0.04% |
| Operating Margin (TTM) | 0.13% | 0.05% |
| Return on Equity (TTM) | 0.06% | -0.04% |
| Debt to Equity (MRQ) | 38.26 | 81.95 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $122.25 | $64.30 |
| Cash per Share (MRQ) | $6.14 | $4.34 |
| Operating Cash Flow (TTM) | $1.14B | $737.65M |
| Levered Free Cash Flow (TTM) | $925.35M | $572.38M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Icon plc vs Charles River Laboratories International, Inc.
| Metric | ICLR (Apr 23, 2026) | CRL (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.52 | 681.33 |
| Forward P/E | 9.42 | 13.59 |
| PEG Ratio | -0.16 | 20.54 |
| Price to Sales (TTM) | 1.11 | 2.06 |
| Price to Book (MRQ) | 0.94 | 2.61 |
| Market Capitalization | ||
| Market Capitalization | $8.98B | $8.28B |
| Enterprise Value | $11.90B | $10.72B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.47 | 2.67 |
| Enterprise to EBITDA | 7.82 | 12.23 |
| Risk & Other Metrics | ||
| Beta | 1.28 | 1.62 |
| Book Value per Share (MRQ) | $122.25 | $64.30 |
Financial Statements Comparison: Icon plc vs Charles River Laboratories International, Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ICLR (2024) | CRL (2025) |
|---|---|---|
| Revenue/Sales | 8.28B | 4.02B |
| Cost of Goods Sold | 5.85B | 2.69B |
| COGS % of Revenue | 70.6% | 67.0% |
| Gross Profit | 2.44B | 1.32B |
| Gross Margin | 29.4% | 33.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 1.22B | 401.14M |
| Operating Margin | 14.7% | 10.0% |
| EBITDA | 1.69B | 786.81M |
| EBITDA Margin | 20.4% | 19.6% |
| Pre-Tax Income | 869.18M | -99.50M |
| Pre-Tax Income % of Revenue | 10.5% | -2.5% |
| Income Tax | 77.71M | 42.66M |
| Income Tax % of Revenue | 0.9% | 1.1% |
| Net Income (Profit) | 791.47M | -142.16M |
| Profit Margin | 9.6% | -3.5% |
Balance Sheet & Liquidity Metrics
| Metric | ICLR (2024) | CRL (2025) |
|---|---|---|
| Cash & Equivalents | 538.79M | 213.77M |
| Total Current Assets | 3.53B | 1.45B |
| Total Current Assets % of Revenue | 42.6% | 36.0% |
| Total Current Liabilities | 2.80B | 1.12B |
| Total Current Liabilities % of Revenue | 33.8% | 27.9% |
| Long-Term Debt | 3.54B | 2.57B |
| Long-Term Debt % of Revenue | 42.7% | 64.0% |
| Total Shareholders Equity | 9.52B | 3.21B |
| Retained Earnings | 2.72B | 1.39B |
| Retained Earnings % of Revenue | 32.9% | 34.6% |
| Property, Plant & Equipment | 202.71M | 361.42M |
Cash Flow Statement Comparison
| Metric | ICLR (2024) | CRL (2025) |
|---|---|---|
| Operating Cash Flow | 1.26B | 194.22M |
| Operating Cash Flow % of Revenue | 15.3% | 4.8% |
| Capital Expenditures | -168.06M | N/A |
| Free Cash Flow | 1.12B | 518.49M |
| FCF Margin | 13.5% | 12.9% |
| Debt Repayment | -2.68B | -1.35B |
| Common Stock Repurchase | -500.00M | -360.67M |
Short Interest & Institutional Ownership Analysis
| Metric | ICLR | CRL |
|---|---|---|
| Shares Short | 2.90M | 4.59M |
| Short Ratio | 2.72 | 5.18 |
| Short % of Float | 3.82% | 10.71% |
| Shares Outstanding | 76.36M | 49.22M |
| Float Shares | 75.95M | 48.66M |
| % Held by Insiders | 0.67% | 0.85% |
| % Held by Institutions | 112.17% | 110.31% |
| % Held by Public | -12.84% | -11.16% |
Dividend Analysis & Yield Comparison: Icon plc vs Charles River Laboratories International, Inc.
| Metric | ICLR | CRL |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |